Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||NOT KNOWN / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Angina pectoris, Cardiac arrest
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Anaemia (treated with ferrous sulphate); Chest pain (awaiting diagnostic angiogram)
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021152883
Write-up: Cardiac arrest; cardiac cause; This is a spontaneous report from a contactable physician. This is a report received from the MHRA. Regulatory authority report number GB-MHRA-WEBCOVID-202102111011108460, Safety Report Unique Identifier GB-MHRA-ADR 24740421. A 49-year-old female patient received the 1st does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot # unknown) at single dose on 06Feb2021 for covid-19 immunisation. Medical history included anaemia, chest pain awaiting diagnostic angiogram. Unsure if patient has had symptoms associated with COVID-19. Patient had not a COVID-19 test. Patient was not enrolled in clinical trial. Concomitant medication were unknown. The patient previously took ferrous sulphate (manufacturer unknown, tablets) for anaemia. The patient experienced cardiac arrest and cardiac cause on 06Feb2021. Therapeutic measures were taken as a result of events. The patient died on 06Feb2021. Outcome of events was fatal. It was not reported if an autopsy was performed. Course of events: Patient had COVID vaccine approximately 10-15 mins prior to presenting with cardiac arrest in the Emergency Department. She was brought in by her husband who noted she put her hands to her chest and grasped prior to collapse in the car after the vaccine. She was then brought round to A&E where cardiopulmonary resuscitation (CPR) was started. She was noted to be in PEA arrest and doses of adrenaline (1:10 000), with IV Fluids. Cardiac Arrest Team decided to thrombolyse her given possible cardiac cause given recent history. She was subsequently thrombolysed with tenecteplase. However she did not regain output and CPR was stopped approximately 70 mins after she presented. Patient has not tested positive for COVID-19 since having the vaccine. No follow-up attempts are possible; Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166